Clinical Trial Update: A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating SB1518 in patients with advanced lymphoid malignancies (Hodgkin lymphoma and non-Hodgkin lymphoma) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• SB1518

Snippet

Sponsor: S*BIO | Conditions: Lymphoma, Malignant, Hodgkin's Lymphoma | Phase 1 | Status: COMPLETED